Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Alexander M.M. Eggermont, Domenico Bellomo, Suzette M. Arias‐Mejias, Enrica Quattrocchi, Sindhuja Sominidi‐Damodaran, Alina G. Bridges, Julia S. Lehman, Tina J. Hieken, James W. Jakub, Dennis H. Murphree, Mark R. Pittelkow, Jason C. Sluzevich, Mark A. Cappel, Sanjay P. Bagaria, Charles Perniciaro, Félicia Tjien-Fooh, Barbara Rentroia‐Pacheco, Renske Wever, Martin H. van Vliet, Jvalini Dwarkasing, Alexander Meves